|
1. Guzmán-Blanco M, Labarca JA, Villegas MV, Gotuzzo E. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 2014; 18(4): 421-33. 2. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8(3): 159-66. 3. Falade AG, Ayede AI. Epidemiology, etiology and management of childhood acute community-acquired pneumonia in developing countries--a review. Afr J Med Med Sci 2011; 40(4): 293-308. 4. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012; 27(2): 128-42. 5. Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, et al. Epidemiology and antimicrobial susceptibility profiles of gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2012; 40 Suppl: S37-43. 6. Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Infect Dis Clin North Am 2009; 23(4): 817-45. 7. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumonia carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65(6): 1119-25. 8. Gootz TD. The global problem of antibiotic resistance. Crit Rev Immunol 2010; 30(1): 79-93. 9. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011; 11(5): 381-93. 10. Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother 2007; 60(3): 470–82. 11. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl 1): S19–45. 12. da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC) producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert Opin Biol Ther 2012; 12(6): 663-71. 13. Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. Structure of New Delhi Metallo-β-Lactamase 1 (NDM-1). Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67(Pt 10): 1160-4. 14. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. Wayne PA, USA 2012. 21th informational supplement, M100-S22. 15. Cuzon G, Naas T, Nordmann P. KPC carbapenemases: what is at stake in clinical microbiology?. Pathol Biol (Paris) 2010; 58(1): 39-45. 16. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumonia isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30(7): 666-71. 17. Hashemizadeh F, Zamanzad B, Jahandideh S, Ansari N, Gholipour A, Hashemizadeh F, et al. Identification of KPC-producing Klebsiella pneumoniae in clinical samples in Iran. Yafteh 2013; 15(1): 105-14. 18. Shokri D, Mobasheri Zadeh S, Norouzi Baruq M, Yaran M. Isolation and identification of carbapenemase KPC producing strains of Enterobacteriaceae and determination of their antibiotic susceptibility patterns. J Isfahan Med Sci 2013; 31(248): 1247-56. 19. Mohammadimehr M, Feizabadi M, Bahadori A. Antibiotic resistance pattern of gram negative bacilli caused nosocomial infections in ICUs in khanevadeh and golestan hospital in Tehran-2007. Ann Mil Health Sci Res 2011; 8(4): 283-90. 20. Langarizadeh N, Ahangarzadeh Rezaee M, Aghazadeh M, Hasani A. Prevalence of multi-drug resistant (MDR) Klebsiella pneumonia among children and adults with urinary tract infection referred to Tabriz teaching hospitals. Quarterly J Biol Sci 2011; 1(4): 9-17. 21. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005; 56(1): 128-32. 22. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2008; 52(2): 570-3. 23. Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D. High prevalence of KPC-2-Type carbapenemase coupled with CTX-M-type extended-spectrum β-Lactamases in carbapenem-resistant Klebsiella pneumoniain a teaching hospital in China. Antimicrob Agents Chemother 2011; 55(5): 2493-4.
|
.png){kind=logo}
